Status Finished Effective start/end date 11/02/22 → 11/02/25
Alzheimer's Disease
Pharmacology, Toxicology and Pharmaceutical Science
100%
Combination Therapy
Pharmacology, Toxicology and Pharmaceutical Science
100%
Oligomer
Pharmacology, Toxicology and Pharmaceutical Science
33%
Cognitive Defect
Pharmacology, Toxicology and Pharmaceutical Science
16%
Amyloid Protein
Pharmacology, Toxicology and Pharmaceutical Science
16%
Nervous System Inflammation
Pharmacology, Toxicology and Pharmaceutical Science
16%
Disease Exacerbation
Pharmacology, Toxicology and Pharmaceutical Science
16%
Anti-Inflammatory Drug
Pharmacology, Toxicology and Pharmaceutical Science
16%